-
Why I'm Staying Away From Affinia Therapeutics' IPO For Now
19 Jan 2022 16:08 GMT
… bottom-line losses. After the initial public offering, Affinia will see a large capital … Doesn't Treat Preclinical IPOs Well History is a great … initial public offering in 2021 is down significantly from the IPO price. And if Affinia …
-
Affinia Therapeutics: Rationally Designed Novel Gene Therapies
13 Jan 2022 13:55 GMT
… 's platform named Affinia Rationally-designed Therapies (… $100 million from an initial public offering of shares of common stock … net proceeds from the IPO, together with its existing … equivalents together with the IPO proceeds will be sufficient …
-
U.S. IPO Weekly Recap: Biotechs Ring In The New Year In A 4 IPO Week
09 Jan 2022 06:12 GMT
… neurodegenerative diseases. Nine IPOs submitted initial filings. … digital enterprise-focused businesses. Affinia Therapeutics (AFTX) $100M … Capital's IPO ETF (IPO) tracks the index, … Renaissance Capital’s International IPO ETF (IPOS) tracks the index, …
-
Affinia Therapeutics Announces Addition of Gene Therapy Scientific and Medical Experts to Leadership Team to Advance Novel Gene Therapy Platform and Programs to the Clinic
17 Feb 2021 11:30 GMT
… conventional AAV serotypes. At Affinia Therapeutics, we are … the following individuals on Affinia Therapeutics’ leadership and … IPOs and M&As. About Affinia Therapeutics
At Affinia … . www.affiniatx.com. Affinia Therapeutics Contacts Investors:
investors …
-
Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer
29 Apr 2024 12:10 GMT
… Stoke’s highly successful Initial Public Offering in 2019 and the … Financial Officer at Affinia Therapeutics. Before joining Affinia Therapeutics, Mr … and $231 million IPO. Before joining Black Diamond … three financings, including an IPO. Mr. Leggett spent …
-
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More
01 May 2020 12:57 GMT
… public, ADC Therapeutics resubmitted its IPO paperwork to support a regulatory … a gene therapy partnership with Affinia Therapeutics. The agreement calls for … Affinia to develop novel capsids—protein …
-
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More
03 Apr 2020 14:34 GMT
… with a $165.2 million IPO to support clinical development of … 1 testing.
—Waltham, MA-based Affinia Therapeutics raised $60 million in …